SCHEMBL21187154

SCHEMBL21187154

C/N=C(\Nc1ccc(F)cc1)NC1CCC(c2ccnc(C)c2F)CC1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.36
RAB9A P51151 3/20 0.36
EPHX1 P07099 1/20 0.36
IDO1 P14902 7/20 0.36
CYP2C9 P11712 2/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C8 P10632 1/20 0.36
TDO2 P48775 1/20 0.36
KCNH2 Q12809 1/20 0.36
KMT2A Q03164 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
MEN1 O00255 1/20 0.34
RECQL P46063 1/20 0.34
TP53 P04637 1/20 0.33
KIT P10721 1/20 0.33
PDGFRA P16234 1/20 0.33
KDR P35968 1/20 0.33
MET P08581 1/20 0.33
EPHX2 P34913 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21187097 0.92 IDO1 (0.40) NPC1RAB9AEPHX1IDO1CYP2C9
SCHEMBL21187159 0.91 IDO1 (0.37) NPC1RAB9AEPHX1IDO1CYP2C9
SCHEMBL21187092 0.90 EPHX2 (0.38) NPC1RAB9AEPHX1IDO1CYP3A4
SCHEMBL21187221 0.84 IDO1 (0.39) NPC1RAB9AEPHX1IDO1CYP2C9
SCHEMBL21187158 0.84 PDE4B (0.37) KDRMET
SCHEMBL21187096 0.84 MEN1 (0.39) NPC1RAB9AEPHX1IDO1CYP3A4
SCHEMBL21187173 0.77 IDO1 (0.63) IDO1CYP2C9CYP3A4CYP2C8TDO2
SCHEMBL16877207 0.74 TLR8 (0.39) IDO1CYP3A4KCNH2
SCHEMBL21187168 0.69 GRM4 (0.41) RAB9AIDO1CYP2C9CYP3A4CYP2C8
SCHEMBL21187156 0.69 NPC1 (0.43) NPC1RAB9AKMT2ASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019141095-A1 AMIDINE AND GUANIDINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 四川科伦博泰生物医药股份有限公司 2019-07-25 WO disclosed